Company: ARTL
Filing Date: 2025-10-31
Form Type: 8-K
Source: 0001640334-25-001930
Chunk: 1

Company: ARTELO BIOSCIENCES, INC.
Filing Date: 2025-10-31
Form: 8-K
Item: Item 1.01
Chunk 1
---
 or Warrant to the extent that such conversion or exercise would result in the number of shares of Common Stock beneficially owned by such holder and its affiliates exceeding 4.9% of the total number of shares of Common Stock outstanding immediately after giving effect to the conversion or exercise, which percentage may be increased or decreased at the holder’s election not to exceed 19.9%.

Pursuant to the Subscription Agreement, the Company agreed (i) to file a registration statement (the “ Registration Statement”) with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended (the “ Securities Act”) on or before the 20thcalendar day following the Closing Date (subject to certain exceptions) for purposes of registering the resale of the Converted Shares, if any, and the shares of Common Stock issuable pursuant to the Warrants (collectively, the “ Registrable Shares”), (ii) to use its reasonable best efforts to have such registration statement declared effective within the time period set forth in the Subscription Agreement, and (iii) to keep the Registration Statement effective until the Registrable Shares covered by such Registration Statement may be sold without volume or manner-of-sale restrictions pursuant to Rule 144, subject to certain conditions.

The Subscription Agreement contain customary representations, warranties and agreements by the Company, indemnification obligations of the Company and the Investors, including for liabilities under the Securities Act, and other obligations of the parties. The representations, warranties and covenants contained in the Subscription Agreement were made only for purposes of the Subscription Agreement and are made as of specific dates; are solely for the benefit of the parties (except as specifically set forth therein); may be subject to qualifications and limitations agreed upon by the parties in connection with negotiating the terms of the Subscription Agreement, instead of establishing matters as facts; and may be subject to standards of materiality and knowledge applicable to the contracting parties that differ from those applicable to the investors generally. Investors should not rely on the representations, warranties and covenants or any description thereof as characterizations of the actual state of facts or condition of the Company.

As detailed in the table below, certain directors and officers of the Company entered into the Subscription Agreement in connection with the Offering and purchased Notes and Warrants in the Offering:

  Name                 Affiliation with          Principal Amount      Shares of Common Stock  
                                                                                               
                       the Company                    of the Note      Subject to the Warrant  
 ───────────────────────────────────────────────────────────────────────────────────────────────
  Connie Matsui        Director                       $